RVTY - Revvity Inc Stock Analysis
Revvity Inc (RVTY) is a publicly traded company listed on the NYSE. It operates in the Diagnostics & Research industry, part of the broader Healthcare sector. The company has a market capitalization of 10.51B, generates annual revenue of 2.81B, and reports net income of 238.47M. As of the latest data, the stock is trading at 92.73 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is trading at a high valuation compared to the market average, suggesting investor optimism or growth expectations. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (0.29%) is modest, often associated with growth-oriented companies. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Hold (3.88), indicating current market sentiment. Institutional ownership is reported at 103.68%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -22.95%, trading within a 52-week range of 81.36 - 128.29.
RVTY - Revvity Inc
92.73
Analyst Consensus
Hold 3.88
RVTY – Analyst Rating Summary
- Strong Buy: 7
- Buy: 10
- Hold: 8
- Sell: 1
- Strong Sell: 0
- Total Analysts: 26
| Index: | S&P 500 | P/E: | 46.37 | EPS (ttm): | 2.00 | Insider Own: | 0.43% | Shs Outstand: | 114.03M | Perf Week: | 2.15% |
| Market Cap: | 10.51B | Forward P/E: | 17.49 | EPS next Y: | 5.30 | Insider Trans: | -0.23% | Shs Float: | 112.89M | Perf Month: | -1.35% |
| Income(ttm): | 238.47M | PEG: | 7.79 | EPS next Q: | 1.54 | Inst Own: | 103.68% | Short Float: | 6.80% | Perf Quarter: | 3.39% |
| Revenue(ttm): | 2.81B | P/S: | 3.74 | EPS this Y: | 0.17% | Inst Trans: | 3.84% | Short Ratio: | 6.13 | Perf Half Y: | -0.57% |
| Book/sh: | 64.68 | P/B: | 1.43 | EPS next Y: | 8.04% | ROA: | 1.87% | Short Interest: | 7.68M | Perf Year: | -22.95% |
| Cash/sh: | 8.23 | P/C: | 11.27 | EPS next 5Y: | 5.95% | ROE: | 3.04% | 52W Range: | 81.36 - 128.29 | Perf YTD: | -16.92% |
| Dividend Est.: | 0.27 (0.29%) | P/FCF: | 21.24 | EPS past 3/5Y: | -33.21% 3.37% | ROIC: | 2.35% | 52W High: | 128.29 -27.72% | Beta: | 1.07 |
| Dividend TTM: | 0.28 (0.30%) | Quick Ratio: | 1.44 | Sales past 3/5Y: | -10.38% -0.91% | Gross Margin: | 48.22% | 52W Low: | 81.36 13.97% | Perf 5Y: | -27.61% |
| Dividend Ex-Date: | Jan 16, 2026 | Current Ratio: | 1.75 | EPS Y/Y TTM: | -18.80% | Oper. Margin: | 14.78% | RSI (14): | 50.08 | Volatility: | 2.13% 2.99% |
| Employees: | 11000 | Debt/Eq: | 0.46 | Sales Y/Y TTM: | 3.37% | Profit Margin: | 8.48% | Recom: | 2.10 | Target Price: | 111.20 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.38 | EPS Q/Q: | -46.77% | Payout: | 11.63% | Rel Volume: | 0.74 | Prev Close: | 93.40 |
| Sales Surprise: | -0.06% | EPS Surprise: | 3.42% | Sales Q/Q: | 2.18% | Earnings: | Oct 27 BMO | Avg Volume: | 1.25M | Price: | 92.73 |
| SMA20: | -1.47% | SMA50: | 2.48% | SMA200: | -4.25% | Undervalued: 19.92% | Volume: | 924,471 | Change: | -0.72% | |
Graham Classic formula value: 36.64
(P/E=8 * 1g) Min value: 25.05
(current P/E * 2g) Max value: 104.65
Average value: 55.45
About Revvity Inc
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.